We analyzed resected BM samples from BC patients for the expression of MEF2C, VEGFR-2, and ß-catenin, as well as for proliferation (Ki-67) and epithelial/endothelial (pan Cytokeratin) markers, which allowed us to establish a relationship between MEF2C expression pattern and disease severity. The gene discussed is MEF2C; the disease is breast cancer.